Monthly Archives: August 2022

//August

Changes to discount deduction arrangements

New arrangements for the application of discount deduction to community pharmacy payments have been agreed by PSNC and the Department of Health and Social Care (DHSC). The new discount deduction system will see the current single scale split into three groups: one each for generic medicines, branded medicines, and appliances. Separate fixed deduction rates have been [...]

The post Changes to discount deduction arrangements appeared first on PSNC Website.

By |August 26th, 2022|Lexpos News|Comments Off on Changes to discount deduction arrangements

Regular staff testing for C-19 to be paused

It is currently recommended that all pharmacy staff test twice-weekly for COVID-19 using a self-administered Lateral Flow Device (LFD) test at home and report their results through the GOV.UK website. Prevalence of COVID-19 in the community has fallen and remains at a comparatively low level as we emerge from the current Omicron wave. This means that [...]

The post Regular staff testing for C-19 to be paused appeared first on PSNC Website.

By |August 26th, 2022|C-19, C-19 testing, COVID-19, Lexpos News|Comments Off on Regular staff testing for C-19 to be paused

Last few days to complete CPAF screening survey

Community pharmacy contractors only have a few days left to complete the Community Pharmacy Assurance Framework (CPAF) screening questionnaire before the deadline of midnight on Wednesday 31st August 2022.   Community pharmacy contractors are reminded that as a result of NHS regulations introduced at the end of 2020, completion of CPAF is now a requirement of the [...]

The post Last few days to complete CPAF screening survey appeared first on PSNC Website.

By |August 26th, 2022|Lexpos News|Comments Off on Last few days to complete CPAF screening survey

Medicine Supply Notification: Methylprednisolone (Medrone®) 4mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Methylprednisolone (Medrone®) 4mg tablets. MSN/2022/072 Tier 2 – medium impact Date of issue 25th August 2022 Methylprednisolone (Medrone®) 4mg tablets will be out of stock from 15th September 2022 until mid-January 2023. Methylprednisolone (Medrone®) 2mg tablets remain available but cannot support [...]

The post Medicine Supply Notification: Methylprednisolone (Medrone®) 4mg tablets appeared first on PSNC Website.

By |August 26th, 2022|Lexpos News|Comments Off on Medicine Supply Notification: Methylprednisolone (Medrone®) 4mg tablets

MHRA Drug Safety Update August 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 1 August 2022) has been published and includes articles on: Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists COVID-19 vaccines and medicines: updates for August 2022 Letters [...]

The post MHRA Drug Safety Update August 2022 appeared first on PSNC Website.

By |August 25th, 2022|Lexpos News|Comments Off on MHRA Drug Safety Update August 2022